The Consequences of Removing Prior Authorization for Buprenorphine in Medicaid-Building an Evidence Base
- PMID: 36219020
- DOI: 10.1001/jamahealthforum.2022.0189
The Consequences of Removing Prior Authorization for Buprenorphine in Medicaid-Building an Evidence Base
Comment on
-
Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs.JAMA Health Forum. 2022 Jun 24;3(6):e221757. doi: 10.1001/jamahealthforum.2022.1757. eCollection 2022 Jun. JAMA Health Forum. 2022. PMID: 35977240 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
